drugset

drugset / Trial / NCT00077987

Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.

NCT00077987 ↗

Phase 2 Completed 84 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Assessment of safety and efficacy of SU11248 in patients with metastatic colorectal cancer who have failed selected previous treatments.

Timeline

Start: 2003-12
Primary completion: —
Completion: 2005-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sunitinib	Small molecule	—	—

Indications